CNTA - CIK 0001847903
Centessa Pharmaceuticals plc has filed 579 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (261 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| New insider ownership | 3 | 2021-05-27 | 2021-05-27 |
| Company correspondence | CORRESP | 2021-05-26 | - |
| S-1/A | - | 2021-05-26 | - |
| Company correspondence | CORRESP | 2021-05-25 | - |
| Company correspondence | CORRESP | 2021-05-25 | - |
| 8-A12B | - | 2021-05-25 | - |
| SEC correspondence | UPLOAD | 2021-05-25 | - |
| S-1/A | - | 2021-05-24 | - |
| F-6 | - | 2021-05-21 | - |
| Company correspondence | CORRESP | 2021-05-20 | - |
| SEC correspondence | UPLOAD | 2021-05-19 | - |
| Company correspondence | CORRESP | 2021-05-12 | - |
| S-1/A | - | 2021-05-12 | - |
| Company correspondence | CORRESP | 2021-05-11 | - |
| SEC correspondence | UPLOAD | 2021-05-11 | - |
| SEC STAFF LETTER | - | 2021-04-21 | - |
| Company correspondence | CORRESP | 2021-04-21 | - |
| IPO registration | S-1 | 2021-04-21 | - |
| SEC correspondence | UPLOAD | 2021-04-14 | - |
| DRS | - | 2021-03-15 | - |